NEW YORK--(BUSINESS WIRE)--
The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased MGC Diagnostics Corporation (“MGC Diagnostics” or the “Company”) (NASDAQ:MGCD) stock prior to November 27, 2017.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of MGC Diagnostics to affiliates of Altus Capital Partners, Inc. Under the terms of the transaction, MGC Diagnostics shareholders will receive $11.03 in cash for each share of MGC Diagnostics stock they own. To learn more about the action and your rights, go to:
http://www.zlk.com/mna/mgc-diagnostics-corporation
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The investigation concerns whether the Board of MGC Diagnostics breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Altus Capital Partners, Inc. is underpaying for MGC Diagnostics shares, thus unlawfully harming MGC Diagnostics shareholders.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171127005697/en/
